Stephen M. Bloch
Independent ChairmanDr. Stephen M. Bloch, also known as Steve, M.D., is a Co-Founder of Allyx Therapeutics, Inc. and serves as its Chief Executive Officer. He serves as Observer at Iantrek, Inc. He serves as Co-Founder, Director and CEO at Evolveimmune Therapeutics Inc. Dr. Bloch serves as a Director of Allyx Therapeutics, Inc. since 2023 and had been its Director. He serves as President, CEO and Director of EvolveImmune Therapeutics Holding Company, LLC. He serves as General Partner at Canaan Partners since November 2007. Dr. Bloch is focused on investments in biopharmaceuticals, therapeutics, medical devices and diagnostics and healthcare infrastructure. Dr. Bloch is a part of the healthcare team and focuses on healthcare IT and related services. From August 2003 to November 2007, Dr. Bloch was a principal at Canaan Partners. Dr. Bloch joined Canaan in June 2002. From January 1995 to June 2002, Dr. Bloch was the founder and chief executive officer of Radiology Management Sciences, LLC. He also helped start Omnisonics Medical Technologies, Inc and served as its Medical Director. Dr. Bloch co-founded TeleRad and was an initial investor in OpenAir.com. He was Strategic Consultant focusing on pharmaceuticals and medical devices at Arthur D. Little and started his career as a practicing Radiologist. He serves as the chairman of the Crossroads Venture Group and Axial Exchange, Inc. He served as Chairman of Shire Regenerative Medicine, Inc. He serves as a Director of LQ3 Pharmaceuticals, Inc., Envisia Therapeutics Inc., Cylex, Inc and Shire Regenerative Medicine, Inc. He has been an Independent Director of Liquidia Corporation since July 2009 and serves as its Independent Chairman of the Board since October 2018. Dr. Bloch serves as a Director of Advanced BioHealing Inc., Immunology Partners, Ambra Health, Inc. (formerly known as DICOM Grid, Inc.), Mitraspan, Truveris, Inc., Viacor, Inc. and a Board Observer of CombinatoRx, Immunicon and Genaissance Pharmaceuticals. He serves on the Board of Directors at Onkos Surgical, Inc. He has been a Director of Corvium, Inc. (formerly known as Sample6, Inc.). since October 9, 2013. He served as Director of Marinus Pharmaceuticals Inc. from September 2005 until April 2016. He served as the Chairman of Marinus Pharmaceuticals, Inc. since October 2007 and served as its Independent Director from September 2005 to April 19, 2016. Dr. Bloch served as the Chairman of Advanced BioHealing Inc. since November 29, 2005. He served as Director of OmniSonics Medical Technologies, Inc. He served as Director of Amicus Therapeutics Inc. from 2004 to February 18, 2009. Dr. Bloch received his medical training as a Radiologist at The Massachusetts General Hospital at Harvard Medical School and in Internal Medicine at The Lenox Hill Hospital at Cornell Medical School. He received Doctor of Medicine from the University of Rochester and was honored as a Ewing Marion Kauffman Fellow in 2002. Dr. Bloch served as a Director at Genome Medical Holding Co (formerly known as Genome Medical, Inc.). Dr. Bloch also received Master of Arts in history of science and public policy from Harvard University and Bachelor of Arts degree in history from Dartmouth College.
Positions
- Company NameLiquidia CorporationStock CodeLQDAPositionIndependent ChairmanColleagues
- RARoger A. JeffsCEO & Director
- MKMichael KasetaCOO & CFO
- RSRussell SchundlerChief Strategy Officer, General Counsel & Corporate Secretary
- SMScott MoomawChief Commercial Officer
- RSRajeev SaggarChief Medical Officer
- ASArthur S. KirschIndependent Director
- JCJoanna Caroline HorobinIndependent Director
- RSRamandeep SinghIndependent Director
